| Development and validation of a risk score to predict QT interval prolongation in hospitalized patients JE Tisdale, HA Jaynes, JR Kingery, NA Mourad, TN Trujillo, ... Circulation: Cardiovascular Quality and Outcomes 6 (4), 479-487, 2013 | 424 | 2013 |
| Opioid pharmacokinetic drug-drug interactions. BR Overholser, DR Foster The American journal of managed care 17, S276-87, 2011 | 191 | 2011 |
| Biostatistics primer: part 2 BR Overholser, KM Sowinski Nutrition in clinical practice 23 (1), 76-84, 2008 | 187 | 2008 |
| Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin MB Kays, BR Overholser, BA Mueller, SM Moe, KM Sowinski American journal of kidney diseases 42 (6), 1253-1259, 2003 | 114 | 2003 |
| Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective … JE Tisdale, HA Wroblewski, BR Overholser, JR Kingery, TN Trujillo, ... Drug safety 35, 459-470, 2012 | 103 | 2012 |
| Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients JE Tisdale, HA Jaynes, JR Kingery, BR Overholser, NA Mourad, ... Circulation: Cardiovascular Quality and Outcomes 7 (3), 381-390, 2014 | 90 | 2014 |
| Determination of gatifloxacin in human serum and urine by high-performance liquid chromatography with ultraviolet detection BR Overholser, MB Kays, KM Sowinski Journal of Chromatography B 798 (1), 167-173, 2003 | 79 | 2003 |
| Drug-induced atrial fibrillation Y Kaakeh, BR Overholser, JC Lopshire, JE Tisdale Drugs 72, 1617-1630, 2012 | 77 | 2012 |
| The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients JV Pergolizzi, L Ma, DR Foster, BR Overholser, KM Sowinski, RT Jr, ... Journal of Managed Care Pharmacy 20 (5), 467-476, 2014 | 57 | 2014 |
| Efavirenz Inhibits the Human Ether‐A‐Go‐Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers AM Abdelhady, T Shugg, N Thong, JBL Lu, Y Kreutz, HA Jaynes, ... Journal of cardiovascular electrophysiology 27 (10), 1206-1213, 2016 | 53 | 2016 |
| Sex‐related differences in the pharmacokinetics of oral ciprofloxacin BR Overholser, MB Kays, A Forrest, KM Sowinski The Journal of Clinical Pharmacology 44 (9), 1012-1022, 2004 | 41 | 2004 |
| The influence of an elective introductory clinical research course on pharmacy student interest in pursuing research-based careers BR Overholser, DR Foster, JR Henry, KS Plake, KM Sowinski American journal of pharmaceutical education 74 (9), 165, 2010 | 39 | 2010 |
| Influence of oral progesterone administration on drug-induced QT interval lengthening: a randomized, double-blind, placebo-controlled crossover study JE Tisdale, HA Jaynes, BR Overholser, KM Sowinski, DA Flockhart, ... JACC: Clinical Electrophysiology 2 (7), 765-774, 2016 | 34 | 2016 |
| MicroRNA 362-3p reduces hERG-related current and inhibits breast cancer cells proliferation AA Assiri, N Mourad, M Shao, P Kiel, W Liu, TC Skaar, BR Overholser Cancer genomics & proteomics 16 (6), 433-442, 2019 | 30 | 2019 |
| Iterative development and evaluation of a pharmacogenomic-guided clinical decision support system for warfarin dosing BL Melton, AJ Zillich, JJ Saleem, AL Russ, JE Tisdale, BR Overholser Applied clinical informatics 7 (04), 1088-1106, 2016 | 27 | 2016 |
| Biostatistics primer: part I BR Overholser, KM Sowinski Nutrition in Clinical Practice 22 (6), 629-635, 2007 | 27 | 2007 |
| A retrospective cohort study of a nurse-driven computerized insulin infusion program versus a paper-based protocol in critically ill patients JW Bouw, N Campbell, MA Hull, R Juneja, O Guzman, BR Overholser Diabetes technology & therapeutics 14 (2), 125-130, 2012 | 24 | 2012 |
| Pharmacogenomics of methadone: a narrative review of the literature S Packiasabapathy, BW Aruldhas, N Horn, BR Overholser, SK Quinney, ... Pharmacogenomics 21 (12), 871-887, 2020 | 23 | 2020 |
| High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis HA Wroblewski, RJ Kovacs, JR Kingery, BR Overholser, JE Tisdale Antimicrobial agents and chemotherapy 56 (8), 4495-4499, 2012 | 23 | 2012 |
| Recommended basic science foundation necessary to prepare pharmacists to manage personalized pharmacotherapy LH Cavallari, BR Overholser, D Anderson, E Boyce, L Buie, CM Formea, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (6 …, 2010 | 23 | 2010 |
